Conquering Diseases

Study Of An Investigational Drug For Non-Small Cell Lung Cancer That Has Spread


People with non-small cell lung cancer that has spread outside their lungs and whose tumor has a particular biomarker are sought for a study of an investigational drug.


We are studying the use of an investigational drug for non-small cell lung cancer tumors with biomarkers that are positive for either Loss of Heterozygosity (LOH) or BRCA 1/2. We want to assess whether using biomarkers to guide treatment and using the investigational drug will shrink the tumor and prevent it from returning.

What we're hoping for

We hope that using information from a lung tumor to decide what treatments should be used will lower the chance of lung cancer growing or spreading.

Additional Information Identifier: NCT03845296

 Principal Investigator

William  Walsh, MD

UMass Memorial Health Care

 Study Contact

The Cancer  Research Office



UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655